The newly Grammy-nominated rap star Rod Wave is no stranger to Chicago’s character-building cold weather. The Floridian has been bringing Chicago fans along on his journey to superstardom since he was ...

The professor, Nuno F.G. Loureiro, was pronounced dead at a hospital on Tuesday morning. The authorities said they had opened a homicide investigation. By Michael Levenson The authorities said on ...

Honesdale Borough Council unanimously approved on Nov. 24 a resolution making 12th Street one-way with a single lane, from Church Street to Main Street, which does not go unto effect until the pending ...

Paul Thomas Anderson‘s One Battle After Another, the Leonardo DiCaprio-starring Warner Bros pic that has been leading the charge this awards season since hitting theaters in late September, will debut ...

Quantum computing is becoming a new focus for tech sector investors. D-Wave's approach to building quantum computers differs from most of its competitors. While the company has achieved a bit of ...

The quantum computing pure play is building an unusual architecture compared to its peers. Throughout the artificial intelligence (AI) revolution, investors have primarily turned to companies that ...

Dec 13 (Reuters) - Brazil's Lucas "Chumbo" Chianca survived two brutal wipeouts to claim another Nazare Big Wave Challenge title in huge, clean waves in Portugal on Saturday, while France's Justine ...

The 12-team College Football Playoff bracket is set, and the games begin on Dec. 19. The first round is hosted by the higher seed before the games shift to neutral sites. Here is you need to know: 11 ...

Krispy Kreme fans can get a dozen Original Glazed donuts for just $1, for one day only—Friday, December 12—as its annual “Day of the Dozens” returns. Krispy Kreme announced it will revive its ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...

Wave Life Sciences Ltd. (NASDAQ: WVE) on Monday shared interim data from the lowest therapeutic cohort of the ongoing first-in-human INLIGHT trial evaluating WVE-007, an investigational INHBE ...